1. Guarro J, Akiti T, Almada-Horta R, Leite-Filho LM, Gené J, Ferreira-Gomes S, et al. Mycotic Keratitis due to curvularia senegalensis and in vitro antifungal susceptibilities of curvularia spp. J Clin Microbiol. 1999; 37(12):4170-3.
2. Rachitskaya AV, Reddy AK, Miller D, Davis J, Flynn HW, Smiddy W, et al. Prolonged Curvularia endophthalmitis due to organism sequestration. JAMA Ophthalmol. 2014; 132(9):1123-6.
3. Carter E, Boudreaux C. Fatal cerebral phaeohyphomycosis due to Curvularia lunata in an immunocompetent patient. J Clin Microbiol. 2004; 42(11):5419-23.
4. Alex D, Li D, Calderone R, Peters SM. Identification of Curvularia lunata by polymerase chain reaction in a case of fungal endophthalmitis. Med Mycol Case Rep. 2013; 2:137-40.
5. Chiu ES, Capel B, Press R, Aston SJ, Jelks EB, Jelks GW. Successful management of orbital cellulitis and temporary visual loss after blepharoplasty. Plastic Reconstruct Surg. 2006; 118(3):67e-72e.
6. Denning DW, Stevens DA. Antifungal and surgical treatment of
invasive Aspergillosis: review of 2,121 published cases. Rev Infect Dis. 1990; 12(6):1147-201.
7. Dortzbach RK, Segrest DR. Orbital Aspergillosis. Ophthalmic Surg. 1983; 14(3):240-4.
8. Garcia GH, Harris GJ. Criteria for nonsurgical management of subperiosteal abscess of the orbit: analysis of outcomes 1988–1998. Ophthalmology. 2000; 107(8):1454-6.
9. Casqueiro J, Casqueiro J, Alves C. Infections in patients with diabetes mellitus: a review of pathogenesis. Indian J Endocrinol Metab. 2012; 16(Suppl 1):S27.
10. Vijayabala GS, Annigeri RG, Sudarshan R. Mucormycosis in a diabetic ketoacidosis patient. Asian Pac J Trop Biomed. 2013; 3(10):830-3.
11. Afroze SN, Korlepara R, Rao GV, Madala J. Mucormycosis in a diabetic patient: a case report with an insight into its pathophysiology. Contemp Clin Dent. 2017; 8(4):662-6.
12. Ibrahim AS, Spellberg B, Walsh TJ, Kontoyiannis DP. Pathogenesis of mucormycosis. Clin Infect Dis. 2012; 54(Suppl 1):S16-22.
13. Nucci M, Queiroz-Telles F, Tobón AM, Restrepo A, Colombo AL. Epidemiology of opportunistic fungal infections in Latin America. Clin Infect Dis. 2010; 51(5):561-70.
14. Silveira F, Nucci M. Emergence of black moulds in fungal disease: epidemiology and therapy. Curr Opin Infect Dis. 2001; 14(6):679-84.
15. Brandt ME, Warnock DW. Epidemiology, clinical manifestations, and therapy of infections caused by dematiaceous fungi. J Chemother. 2003; 15(Suppl 2):36-47.
16. Revankar SG, Sutton DA. Melanized fungi in human disease. Clin Microbiol Rev. 2010; 23(4):884-928.
17. Safdar A. Curvularia-favorable response to oral itraconazole therapy in two patients with locally invasive phaeohyphomycosis. Clin Microbiol Infect. 2003; 9(12):1219-23.